Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Among men who had persistent prostate-specific antigen (PSA) after radical prostatectomy (RP), a higher preoperative PSA ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

Prostate cancer is the most common cancer among men in the UK. Leading data and analytics company GlobalData epidemiologists ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA ...

Prostate Cymru aim to test thousands of men in Wales for signs of the disease, but the charity said many face difficulties in ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...